ViiV Healthcare (GSK) Director, Strategic Pricing, Contracting and Reimbursement – HIV Treatment Portfolio
ViiV Healthcare
Summary
Reporting to the Sr. Director of Strategic Pricing, Contracting and Reimbursement (SPCR), the Director, SPCR – HIV Treatment Portfolio is responsible for developing pricing, contracting & reimbursement strategies for payer, institutional & provider customer channels in the US for in-market product(s) specific to HIV Treatment. This position is an integral role within the US Market Access function and involves significant levels of matrix partnership to influence stakeholders and manage priorities as well as cross-functional teamwork to assess the external environment, derive customer insights, and develop tailored strategies across channels and amid a dynamic US payer landscape.
Job description
Key Responsibilities
- Lead, develop and implement pricing and contracting strategies for HIV treatment in-line brands; includes development and management of guidelines across all customer channels
- Lead, develop and implement customer segment contracting strategies to support both the brand and market access strategies
- Lead contract performance evaluation including forecasting, evaluation of key measures and development of recommendations
- Support ViiV Governance process for pricing including cross-functional consultation and evaluation with brand, legal, and contract operations
- Lead development and maintenance of brand gross-to-net financial impact modeling (public policy proposals, contract strategies, investor relations requests, etc)
- Assess US payer environmental trends and healthcare policy changes, and lead impact assessments to determine implications to ViiV portfolio
- Lead evaluations of pharmaceutical industry pricing actions and strategies for ViiV portfolio
- Lead evaluations and monitor impacts of reimbursement methodologies across payer and provider channels; develop strategies and financial models to forecast and monitor quarterly
- Lead independent review function for government pricing calculations and submissions, in partnership with GSK
- Lead pricing analysis for competitive products including impact to ViiV portfolio
- Collaborate within and beyond market access to bring stakeholders along, simplify the complex and elevate organizational market access acumen and understanding
- Partner with Market Access Strategy team to optimize understanding of the customer landscape and integrate price into the overall value narrative
- Transparently communicate about the access landscape and support the cross-functional triaging of access and reimbursement issues
- Supervise, coach, develop and evaluate direct report(s) including normal and customary supervisory responsibilities such as budget management, performance evaluation, coaching, development, recruitment, etc.
- Demonstrate superior interpersonal skills with ability to lead, influence, and gain alignment cross-functionally
- Set priorities and provide clear recommendations in complex and ambiguous circumstances
- Lead and manage vendor relationships
Basic Qualifications
- Bachelor’s degree & 5+ years of US-based pharmaceutical industry experience in finance, market access, marketing and/or related commercial roles
- Experience in commercial and public payer customers (i.e. PBMs, MCO, employer, Medicaid, Medicare) and the dynamics affecting the payer including industry trends, payer and channel economics, and public policy/government regulations
- Experience in financial impact modelling
- Experience leading cross-functional teams across account teams, market access, strategy, and policy functions
Preferred Qualifications
- CPA, MBA, or similar advanced degree in Finance area
- Experience in or understanding of the HIV therapeutic area
- 3+ years of experience in Market Access
- Expertise in payer coverage drivers and implications for provider-administered injectables (benefit placement, coverage criteria, site of care, etc)
- Deep understanding of gross-to-net pricing and revenue analysis, including implications of pricing & contracting on different payer channels
Requirements
- Bachelor’s degree
- 5+ years of US-based pharmaceutical industry experience in finance, market access, marketing and/or related commercial roles
- Experience in commercial and public payer customers (PBMs, MCO, employer, Medicaid, Medicare)
- Experience in financial impact modelling
- Experience leading cross-functional teams across account teams, market access, strategy, and policy functions
- CPA, MBA, or similar advanced degree in Finance area (preferred)
- Experience in or understanding of the HIV therapeutic area (preferred)
- 3+ years of experience in Market Access (preferred)
- Expertise in payer coverage drivers and implications for provider-administered injectables (preferred)
- Deep understanding of gross-to-net pricing and revenue analysis (preferred)
Benefits
- Health Insurance
- Relocation Package
- Comprehensive Benefits Program
Company overview
ViiV Healthcare is a British multinational pharmaceutical company exclusively dedicated to the research, development, and commercialization of medicines for the treatment and prevention of HIV/AIDS. Established in 2009 as a joint venture between GSK and Pfizer, with Shionogi joining in 2012, ViiV Healthcare represents a unique collaboration in the pharmaceutical industry with ownership distributed among GSK (76.5%), Pfizer (13.5%), and Shionogi (10%). As the only global pharmaceutical company 100% focused on HIV, ViiV Healthcare has developed a comprehensive portfolio of antiretroviral therapies including nucleoside reverse transcriptase inhibitors, integrase strand transfer inhibitors, protease inhibitors, and innovative fixed-dose combinations. The company holds approximately 32% of the global HIV therapy market, making it the second-largest player in this specialized sector. With over 1,100 employees worldwide and headquarters in London, ViiV Healthcare operates across multiple continents, maintaining a strong commitment to community engagement, treatment access programs, and partnerships with HIV-affected communities to advance its mission of ending the HIV epidemic.